-
公开(公告)号:US11957720B2
公开(公告)日:2024-04-16
申请号:US17730891
申请日:2022-04-27
发明人: Peter McLean , Gabriela Bergonzelli Degonda , Stephen Michael Collins , Premysl Bercik , Elena Verdu de Bercik
IPC分类号: A61K35/745 , A23K10/18 , A23L33/135 , A61K35/74 , C12N1/20 , A23K20/163 , A23L33/21
CPC分类号: A61K35/74 , A23K10/18 , A23L33/135 , A61K35/745 , C12N1/20 , A23K20/163 , A23L33/21 , A23V2002/00 , A23V2400/533 , A23V2002/00 , A23V2200/32 , A23V2200/3204
摘要: The present invention generally relates to the field of probiotic bacteria. In particular, it relates to methods for treating or preventing functional GI disorders comprising administering Bifidobacterium longum, such as Bifidobacterium longum ATCC BAA-999.
-
公开(公告)号:US20180303857A1
公开(公告)日:2018-10-25
申请号:US15523704
申请日:2015-11-05
申请人: Optibiotix Limited
IPC分类号: A61K31/702 , A61K35/747 , A61P3/04 , A61P3/06 , A61P3/10 , A23L2/52 , A23L33/21
CPC分类号: A61K31/715 , A23L2/52 , A23L29/269 , A23L33/135 , A23L33/21 , A23L33/26 , A23L33/30 , A23V2002/00 , A23V2200/00 , A23V2200/3202 , A23V2200/3262 , A23V2200/328 , A23V2200/332 , A23Y2220/00 , A23Y2220/35 , A23Y2220/71 , A61K9/0053 , A61K9/50 , A61K31/702 , A61K35/741 , A61K35/747 , A61K45/06 , A61K49/0004 , A61P3/04 , A61P3/06 , A61P3/10 , C12Q1/025 , G01N2333/335 , G01N2333/938 , G01N2500/10 , A23V2200/30 , A23V2200/3204 , A23V2250/28 , A61K2300/00
摘要: The present invention relates to a prebiotic composition comprising a galacto oligosaccharide (GOS) produced from Lactobacillus plantarum, wherein the GOS acts as a selective growth medium for a chosen Lactobacillus plantarum probiotic bacterial strain, and wherein the GOS is substantially the same as the form produced by reverse β-galactosidase reaction in the chosen probiotic bacterial strain. The present invention also relates to methods of producing GOS and related composition incorporating the GOS.
-
公开(公告)号:US20180242619A1
公开(公告)日:2018-08-30
申请号:US15757097
申请日:2016-09-01
发明人: Hye Jin KIM , Dong Joo SHIN , Hye Won SHIN , Eun Seok JANG , Dae Ik KANG , Byoung Seok MOON , Seon Mi OH , Sun A CHO
CPC分类号: A23L11/09 , A23L11/00 , A23L11/20 , A23V2002/00 , A23V2200/3204 , A61K36/48 , C12N1/20 , C12P1/04 , C12R1/07 , A23V2200/332
摘要: The present disclosure relates to a Bacillus amyloliquefaciens CJ14-6 strain isolated from traditional meju, a preparation method for soybean koji using the same, and a soybean koji prepared by the preparation method. The preparation method for soybean koji includes: soaking soybeans in water or adding waster to soybeans and steaming the soaked soybeans; and inoculating a Bacillus amyloliquefaciens CJ14-6 strain into the steamed soybeans, fermenting the steamed soybeans, and drying the fermented soybeans to prepare a soybean koji.
-
公开(公告)号:US20180221422A1
公开(公告)日:2018-08-09
申请号:US15747579
申请日:2016-07-08
发明人: Majid Keshtmand , Mordechai Harel , Trisha Rice
IPC分类号: A61K35/747 , A23L33/135 , A23L33/125 , A23L33/00 , A23L33/18 , A23L33/185 , A23L33/15 , A23L2/60 , A61K35/745 , A61K9/00 , A61K9/14
CPC分类号: A61K35/747 , A23L2/52 , A23L2/60 , A23L2/66 , A23L33/125 , A23L33/135 , A23L33/15 , A23L33/18 , A23L33/185 , A23L33/40 , A23V2002/00 , A23Y2220/03 , A61K9/0095 , A61K9/145 , A61K9/146 , A61K35/745 , A23V2200/3202 , A23V2200/3204 , A23V2250/507 , A23V2250/548 , A23V2250/612 , A23V2250/712 , A23V2250/284 , A23V2250/50
摘要: A dry stable probiotic composition is provided. The composition comprises one or more viable probiotic microorganisms, one or more hydrolyzed proteins, one or more disaccharides, one or more oligosaccharides, and one or more polysaccharides, but not trehalose. The composition has viability of at least 1×1010 CFU/g, and a viability loss of less than 1 log unit/g after 3 months at a temperature of 40° C. and a relative humidity of 33%. Also provided are methods for preparing the dry stable probiotic composition.
-
公开(公告)号:US20180202010A9
公开(公告)日:2018-07-19
申请号:US13468374
申请日:2012-05-10
IPC分类号: C12R1/01 , A23C9/123 , A61K35/745 , C12N1/20 , A23L33/135 , A23G9/36
CPC分类号: C12R1/01 , A23C9/1234 , A23G9/363 , A23L33/135 , A23V2002/00 , A23Y2300/55 , A61K35/745 , C12N1/20 , Y02A50/473 , A23V2200/3204 , A23V2200/324
摘要: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
-
公开(公告)号:US10000818B2
公开(公告)日:2018-06-19
申请号:US14350957
申请日:2012-10-12
申请人: Gut Guide Oy
IPC分类号: C12Q1/68 , A61K45/06 , A61K31/702 , A61K35/745 , A61K35/747 , A61B5/00 , A61K35/744 , A23L33/135
CPC分类号: C12Q1/689 , A23L33/135 , A23V2002/00 , A23V2200/00 , A61B5/4872 , A61K31/702 , A61K35/744 , A61K35/745 , A61K35/747 , A61K45/06 , G01N2800/044 , G01N2800/52 , A61K2300/00 , A23V2200/3204 , A23V2200/322 , A23V2200/332
摘要: The invention is based on a correlation observed between visceral fat and gut flora. The invention relates to a product increasing the relative proportion of bifidobacteria in the intestines and to be used for preventing formation of visceral fat or for reducing the amount thereof in the body. In particular, the product increases the ratio of bifidobacteria to Clostridia. The invention also relates to determining visceral fat in the body by determining the relative proportion of bifidobacteria or Clostridia or their ratio to each other in the intestines. The invention further relates to a method for estimating, in the same manner, the health risk associated with obesity.
-
公开(公告)号:US20180119088A1
公开(公告)日:2018-05-03
申请号:US15565558
申请日:2016-03-24
申请人: HER MAJESTY THE QUEEN IN RIGHT OF CANADA, AS REPRESENTED BY THE MINISTER OF AGRICULTURE AND AGR
发明人: Qi WANG , Huan LIU , Jianhua GONG , Hai YU , Qian GUO , Shea MILLER , Wuwei CUI
CPC分类号: C12N1/04 , A23D7/0053 , A23D7/05 , A23D9/05 , A23K40/30 , A23L33/135 , A23P10/30 , A23P10/35 , A23V2002/00 , A61K9/1652 , A61K35/747 , A61K47/42 , B01J13/043 , C12N11/04 , A23V2200/224 , A23V2200/3204 , A23V2250/194 , A23V2250/5028 , A23V2250/54246 , A23Y2220/00
摘要: Microparticles include a matrix of an encapsulating material, in which are dispersed particles of a low melting point fat and a bioactive material, such as one or more probiotic bacteria. The microparticles are formed by preparing an emulsion of melted low melting point fat in an aqueous mixture of the encapsulating material, cooling the emulsion below the melting point of the low melting point fat, dispersing the bioactive material in the emulsion and spray drying the emulsion. The particles of solid low melting point fat are believed to protect the bioactive material from heat damage during the spray drying process.
-
公开(公告)号:US09872892B2
公开(公告)日:2018-01-23
申请号:US14779121
申请日:2014-05-08
申请人: Novozymes A/S
IPC分类号: A61K38/44 , A61K45/06 , A23K10/30 , A23K20/174 , A23K20/142 , A23K20/189 , A23K10/14 , A23K20/195 , A23K20/20 , A23K50/75
CPC分类号: A61K38/443 , A23K10/14 , A23K10/30 , A23K20/142 , A23K20/174 , A23K20/189 , A23K20/195 , A23K20/20 , A23K40/20 , A23K40/25 , A23K50/75 , A23V2002/00 , A61K38/44 , A61K45/06 , A23V2200/3204
摘要: The present invention relates to methods of controlling the growth of microorganisms in animals and animal feed. In particular, the present invention relates to a method of controlling the growth of microorganisms in animals with an antimicrobial composition, the treatment of animal feed with an antimicrobial additive and antimicrobial compositions.
-
公开(公告)号:US20170296563A1
公开(公告)日:2017-10-19
申请号:US15406361
申请日:2017-01-13
申请人: N.V. Nutricia
发明人: Belinda POTAPPEL-VAN 'T LAND , Leon Matthieu Johannes KNIPPELS , Alma Jildou NAUTA , Johan GARSSEN
IPC分类号: A61K31/702 , A61K35/745 , A23L33/40 , A23L33/135 , A61K31/733 , A61K38/01 , A61K35/744
CPC分类号: A61K31/702 , A23L33/135 , A23L33/40 , A23V2002/00 , A61K31/733 , A61K35/744 , A61K35/745 , A61K38/017 , A61K38/018 , A61K2300/00 , A23V2200/324 , A23V2200/3202 , A23V2200/3204 , A23V2250/28
摘要: Disclosed is a nutritional composition comprising a combination of non-digestible oligosaccharides and a product obtained by incubating an aqueous substrate by bifidobacteria and optionally a product obtained by incubating an aqueous substrate by S. thermophilus. Said combination synergistically improves the immune system by stimulating the Th1 response, and/or decreasing the Th2 response, improving the vaccination response, improving the resistance against infections and/or decreasing allergy.
-
公开(公告)号:US09737575B2
公开(公告)日:2017-08-22
申请号:US13130522
申请日:2008-11-28
申请人: Julian Crane , Angela Marie Rowan , Kristin Lee Wickens , Gerald William Tannock , Thorsten Villiers Stanley , Penelope Frances Fitzharris , Edwin Arthur Mitchell , Peter Nigel Black , Bernadette Salmon
发明人: Julian Crane , Angela Marie Rowan , Kristin Lee Wickens , Gerald William Tannock , Thorsten Villiers Stanley , Penelope Frances Fitzharris , Edwin Arthur Mitchell , Peter Nigel Black
IPC分类号: A61K35/74 , A61K35/747 , A61K31/702 , A61K31/733 , A61K45/06 , A23L33/00 , A23L33/135
CPC分类号: A61K35/747 , A23L33/135 , A23L33/40 , A23V2002/00 , A23Y2220/73 , A61K31/702 , A61K31/733 , A61K45/06 , Y10S514/861 , A61K2300/00 , A23V2200/318 , A23V2200/3204
摘要: Use of Lactobacillus rhamnosus HN001 or derivatives thereof to treat or prevent eczema.
-
-
-
-
-
-
-
-
-